Chemed Cash Flow from Operating Activities 2010-2025 | CHE

Chemed cash flow from operating activities for the twelve months ending June 30, 2025 was $0.874B, a 9.46% increase year-over-year.

  • Chemed annual cash flow from operating activities for 2024 was $0.417B, a 26.4% increase from 2023.
  • Chemed annual cash flow from operating activities for 2023 was $0.33B, a 6.59% increase from 2022.
  • Chemed annual cash flow from operating activities for 2022 was $0.31B, a 0.42% increase from 2021.

Chemed Cash Flow from Operating Activities 2010-2025 | CHE

  • Chemed annual cash flow from operating activities for 2024 was $0.417B, a 26.4% increase from 2023.
  • Chemed annual cash flow from operating activities for 2023 was $0.33B, a 6.59% increase from 2022.
  • Chemed annual cash flow from operating activities for 2022 was $0.31B, a 0.42% increase from 2021.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$20.6B
Encompass Health (EHC)$12.4B
DaVita (DVA)$9.8B
Elanco Animal Health (ELAN)$8.7B
RadNet (RDNT)$5.3B
Option Care Health (OPCH)$4.4B
Amedisys (AMED)$3.3B
Addus HomeCare (ADUS)$2.1B
LifeStance Health (LFST)$2.1B
Astrana Health (ASTH)$1.6B
Aveanna Healthcare Holdings (AVAH)$1.5B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$870M
Atai Life Sciences (ATAI)$851M
MEDIROM Healthcare Technologies (MRM)$52M
Daxor (DXR)$52M
Psychemedics (PMD)$0M